Osseointegration Implants Market Highlights, Key Company Profiles, Share Analysis, Global Size and Industry Forecast to 2023

Market Overview:
The global osseointegration implants market is anticipated to post a CAGR of 6.4% over the forecast period of 2017-2023, proclaims Market Research Future (MRFR) in a detailed study. The global osseointegration implants market was stood at USD 4.7 Bn in 2017 and is expected to catapult to USD 6.8 Bn by the end of 2023.
The increasing number of joint replacement surgeries, particularly among the geriatric population, coupled with the growing adoption of minimally invasive surgeries, and striking advancement in healthcare facilities will have a strong impression on the growth of the osseointegration implants market in the coming years.
Also, emerging nations in Latin America and Asia, at present, are witnessing a moderate adoption rate of osseointegration implants, serving to be strong growth opportunities in the near future. Moreover, economic growth paired with the growing disposable income in these economies will elevate the market position to a large extent.

Access Full Report Details and Full TOC Exclusively @ https://www.marketresearchfuture.com/reports/osseointegration-implants-market-6740

Competitive Landscape
·         Danaher Corporation
·         Zimmer Biomet Holdings
·         NuVasive
·         Dentsply Sirona Inc
·         Cochlear Ltd
·         William Demant Holding A/S
·         The Straumann Group
·         Medtronic plc
·         Henry Schein Inc
·         Stryker Corporation
Segmentation
·         The global osseointegration implants market has been segmented based on product, material type, and end user.

·         By product, the global osseointegration implants market has been segmented into bone-anchored prostheses, dental implants, and others. The bone-anchored prostheses segment is the largest segment while the dental implants segment is the fastest-growing segment.

·         By material type, the global osseointegration implants market has been segmented into metallic, ceramic, polymeric and others. The metallic segment is the largest segment while the ceramic segment is expected to be the fastest growing segment.

·         By end user, the global osseointegration implants market has been segmented into hospitals, ambulatory surgical clinics, and others. The hospitals segment is the largest segment while the ambulatory surgical clinics segment is likely to be the fastest growing segment over the forecast period.

Regional Analysis
By region, the global osseointegration implants market has been segmented into the Americas, Asia Pacific (APAC), Europe, and the Middle East & Africa (MEA).

The Americas account for the maximum share of the global osseointegration implants. Fast uptake of latest and technologically advanced treatment options, high healthcare expenditure, well spread awareness regarding osseointegration implants drive the market in the region. Moreover, the growing popularity of cosmetic dentistry and increase in geriatric population are also crucial factors boosting the market growth. The presence of key players is a factor which cannot be missed.

Europe too is a significant revenue pocket which is expected to expand notably over the forecast period.

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com

Comments

Post a Comment

Popular posts from this blog

Proteomics Market Analysis, Demand Overview, Growth Analysis, Current Trends, Updates, and Global Industry Forecast to 2023

Market Highlights: The global proteomics market is anticipated to hold a market value of USD 23.2 billion in the year 2017 and is expected to grow at a CAGR of 14.1% during the forecast period. Proteomics is a science which is used to estimate the rate of protein production, interaction of proteins with one another, involvement of proteins in metabolic pathways, and modification of proteins. Also, it has extensive applications in drug discovery, development of personalized medicines, and identification of markers for disease diagnosis. Increasing need for personalized medicine, R&D expenditure, technological advancements and increased funding for proteomics project are expected to drive the market growth over the forecast period. For instance, in July 2017, Biognosys AG received USD 5 million funding from its new as well as existing investors. These new funds will be used for extending commercial operations and also to accelerate the development of next generation prote...
Read more

Pancreatic Cancer Market: America to Command the Largest Share

Market Overview: Pancreatic cancer can be defined as an enlarged tumor, which is generally caused by malignant cells present in the tissues of the pancreas. This type of cancer is generally caused due to drinking alcohol, smoking, genetic factors, radiotherapy in the past, obesity, inflammation of the pancreas, and diabetes mellitus. It is a type of cancer that starts in the pancreas and is a highly lethal disease. The global Pancreatic Cancer Market , as per a report by Market Research Future (MRFR) is touted to register 8.1% CAGR during the forecast period ( 2017-2023 ). The dearth of therapeutic approaches for early-stage detection has resulted in increased incidences of pancreatic cancer. Soaring prevalence of pancreatic cancer has resulted in germline mutations, thereby causing the defective genes to pass down to the children from their parents, thus making early detection of pancreatic cancer important. This has led to the growth of the market across the globe. Surging dem...
Read more

Immune Thrombocytopenia (ITP) Market is Estimated to Record Promising CAGR of 5.78% During Forecast 2018-2023

Market Highlights: As per the latest report published by Market Research Future (MRFR), the Global Immune Thrombocytopenia (ITP) is set to surpass a valuation of USD 2,300 Mn by the year 2023, reflecting a healthy CAGR. ITP is a blood related disorder that cause abnormal clotting. Some of the discomforts caused by the disease include bruising, bleeding and severe drop in platelets counts. Both minors and adults can develop the condition. The disease is classified into primary and secondary form. Primary form of ITP occurs on its own while the latter is an offshoot of another condition. The condition can be triggered by reactive medications, autoimmune disease, pregnancy and certain type of cancers. ITP is among the most commonly occurring disorder across the globe. In addition, the incidence rate has continued to spiral upwards in recent years. Factors as such as are fueling the demand for drugs and therapeutics for ITP. Currently, there are four treatment options available for ...
Read more